EDGE THERAPEUTICS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by EDGE THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-05-08BlackRock Inc.PDS Biotechnology Corp1,821,6215.0%EDGAR
SC 13G2024-01-29BlackRock Inc.PDS Biotechnology Corp1,881,4386.0%EDGAR
SC 13G/A2021-08-27HIRSCHMAN ORINPDS Biotechnology Corp1,135,3984.0%EDGAR
SC 13D/A2021-06-21NETSCIENTIFIC PLCPDS Biotechnology Corp1,342,6704.7%EDGAR
SC 13G2021-06-21HIRSCHMAN ORINPDS Biotechnology Corp1,750,0006.2%EDGAR
SC 13D/A2020-08-21NETSCIENTIFIC PLCPDS Biotechnology Corp1,282,6705.8%EDGAR
SC 13D2020-03-02NETSCIENTIFIC PLCPDS Biotechnology Corp1,046,6707.2%EDGAR
SC 13G2020-02-21PEIERLS E JEFFREYPDS Biotechnology Corp-7.0%EDGAR
SC 13D/A2019-03-28Sofinnova Venture Partners IX, L.P.PDS Biotechnology Corp142,6352.7%EDGAR
SC 13D/A2019-03-25New Leaf Ventures III, L.P.PDS Biotechnology Corp58,6211.1%EDGAR
SC 13G/A2019-02-13Satter Muneer AEdge Therapeutics, Inc.00.0%EDGAR
SC 13G/A2019-02-11JANUS HENDERSON GROUP PLCEdge Therapeutics, Inc.00.0%EDGAR
SC 13G/A2018-04-10FRANKLIN RESOURCES INCEdge Therapeutics, Inc.2150.0%EDGAR
SC 13G/A2018-02-13JANUS CAPITAL MANAGEMENT LLCEdge Therapeutics, Inc.00.0%EDGAR
SC 13G2018-02-13JANUS HENDERSON GROUP PLCEdge Therapeutics, Inc.2,072,3306.7%EDGAR
SC 13G/A2018-02-09Satter Muneer AEdge Therapeutics, Inc.1,814,0005.9%EDGAR
SC 13G/A2018-02-06FRANKLIN RESOURCES INCEdge Therapeutics, Inc.3,190,22210.3%EDGAR
SC 13G/A2017-10-10FRANKLIN RESOURCES INCEdge Therapeutics, Inc.3,192,27210.3%EDGAR
SC 13G2017-04-25Satter Muneer AEdge Therapeutics, Inc.1,800,0005.8%EDGAR
SC 13G/A2017-02-14JANUS CAPITAL MANAGEMENT LLCEdge Therapeutics, Inc.2,163,5107.5%EDGAR
External links